Intracoronary enalaprilat during angioplasty for acute myocardial infarction: Alleviation of postischaemic neurohumoral and inflammatory stress?

Journal of Internal Medicine

Volumn 261, Issue 2, 2007, Pages 188-200

  Schaefer, U ^a,c   Kurz, T ^a   Bonnemeier, H ^a   Dendorfer, A ^a   Hartmann, F ^a   Schunkert, H ^a   Richardt, G ^b  

^a Campus Lübeck ^*  (Germany)

^b Segeberger Kliniken   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

ACE inhibition; Bradykinin; Endothelin 1; Leukocyte adhesion; Myocardial infarction; Reperfusion

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ENALAPRILAT; HEPARIN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; NEUROHORMONE; NITRIC OXIDE; PADGEM PROTEIN; PLACEBO; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE HEART INFARCTION; ADULT; AGED; ARTERIAL BLOOD; ARTICLE; BLOOD CLOT LYSIS; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG ACTIVITY; DRUG EFFECT; FEMALE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; INFLAMMATION; LEUKOCYTE ADHERENCE; LOADING DRUG DOSE; MALE; METABOLITE; PRIORITY JOURNAL; PROTEIN SECRETION; PULMONARY ARTERY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; STRESS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANALYSIS OF VARIANCE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL MARKERS; COMBINED MODALITY THERAPY; CORONARY VESSELS; ENALAPRILAT; ENDOTHELIN-1; FEMALE; HUMANS; INJECTIONS; L-SELECTIN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; NITRIC OXIDE; NOREPINEPHRINE; P-SELECTIN; PULMONARY ARTERY; RECURRENCE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33846160615     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2006.01757.x     Document Type: Article

References (58)

1. Piper HM, Abdallah Y, Schafer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 2004; 61: 365-71.
2. Entman ML, Smith CW. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res 1994; 28: 1301-11.
3. Li YH, Teng JK, Tsai WC, Tsai LM, Lin LJ, Chen JH. Elevation of soluble adhesion molecules is associated with the severity of myocardial damage in acute myocardial infarction. Am J Cardiol 1997; 80: 1218-21.
4. Sakurai S, Inoue A, Koh CS, Owa M, Yanagisawa N. Soluble form of selectins in blood of patients with acute myocardial infarction and coronary intervention. Vasc Med 1997; 2: 163-8.
5. Zeitler H, Ko Y, Zimmermann C, et al. Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction. Eur J Med Res 1997; 2: 389-94.
6. Verrier ED. The vascular endothelium: friend or foe? Ann Thorac Surg 1993; 55: 818-9.
7. Battistini B, Dussault P. The many aspects of endothelins in ischemia-reperfusion injury: emergence of a key mediator. J Invest Surg 1998; 11: 297-313.
8. Farber HW, Center DM, Rounds S. Bovine and human endothelial cell production of neutrophil chemoattractant activity in response to components of the angiotensin system. Circ Res 1985; 57: 898-902.
9. Grafe M, Auch-Schwelk W, Zakrzewicz A, et al. Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res 1997; 81: 804-11.
10. Zouki C, Baron C, Fournier A, Filep JG. Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor. Br J Pharmacol 1999; 127: 969-79.
11. Brunner F, Kukovetz WR. Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion. Circulation 1996; 94: 1752-61.
12. Kurz T, Schafer U, Dendorfer A, et al. Effects of intracoronary low-dose enalaprilat as an adjunct to primary percutaneous transluminal coronary angiography in acute myocardial infarction. Am J Cardiol 2001; 88: 1351-7.
13. Gibson CM, Murphy SA, Rizzo MJ, et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. Circulation 1999; 99: 1945-50.
14. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-88.
15. Schafer U, Kurz T, Jain D, et al. Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: role of neurohumoral activation? Basic Res Cardiol 2002; 97: 399-408.
16. Sakowitz OW, Wolfrum S, Sarrafzadeh AS, et al. Relation of cerebral energy metabolism and extracellular nitrite and nitrate concentrations in patients after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab 2001; 21: 1067-76.
17. Gibson CM, Ryan KA, Murphy SA, et al. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction. J Am Coll Cardiol 1999; 34: 974-82.
18. Gibson CM, Goel M, Murphy SA, et al. Global impairment of coronary blood flow in the setting of acute coronary syndromes (a RESTORE substudy). Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. Am J Cardiol 2000; 86: 1375-7, A5.
19. Hernandez LA, Grisham MB, Twohig B, Arfors KE, Harlan JM, Granger DN. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol 1987; 253: H699-703.
20. Ma XL, Lefer DJ, Lefer AM, Rothlein R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 1992; 86: 937-46.
21. Simpson PJ, Todd III RF, Fantone JC, Mickelson JK, Griffin JD, Lucchesi BR. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest 1988; 81: 624-9.
22. Wang LX, Ideishi M, Yahiro E, Urata H, Arakawa K, Saku K. Mechanism of the cardioprotective effect of inhibition of the renin-angiotensin system on ischemia/reperfusion-induced myocardial injury. Hypertens Res 2001; 24: 179-87.
23. Linz W, Scholkens BA. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 1992; 20(Suppl. 9): S83-90.
24. Remme WJ, Kruyssen DA, Look MP, Bootsma M, De Leeuw PW. Systemic and cardiac neuroendocrine activation and severity of myocardial ischemia in humans. J Am Coll Cardiol 1994; 23: 82-91.
25. Ertl G. Angiotensin converting enzyme inhibitors and ischaemic heart disease. Eur Heart J 1988; 9: 716-27.
26. Kyriakidis M, Triposkiadis F, Dernellis J, et al. Effects of cardiac versus circulatory angiotensin-converting enzyme inhibition on left ventricular diastolic function and coronary blood flow in hypertrophic obstructive cardiomyopathy. Circulation 1998; 97: 1342-7.
27. Kuga T, Mohri M, Egashira K, et al. Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme. J Am Coll Cardiol 1997; 30: 108-12.
28. Neubauer S, Ertl G, Haas U, Pulzer F, Kochsiek K. Effects of endothelin-1 in isolated perfused rat heart. J Cardiovasc Pharmacol 1990; 16: 1-8.
29. Faxon DP, Gibbons RJ, Chronos NA, Gurbel PA, Sheehan F. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J Am Coll Cardiol 2002; 40: 1199-204.
30. Baran KW, Nguyen M, McKendall GR, et al. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study. Circulation 2001; 104: 2778-83.
31. Ikeda H, Takajo Y, Ichiki K, et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation 1995; 92: 1693-6.
32. Kaikita K, Ogawa H, Yasue H, et al. Soluble P-selectin is released into the coronary circulation after coronary spasm. Circulation 1995; 92: 1726-30.
33. Morisaki N, Saito I, Tamura K, et al. New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease. Atherosclerosis 1997; 131: 43-8.
34. Serebruany VL, Gurbel PA. Effect of thrombolytic therapy on platelet expression and plasma concentration of PECAM-1 (CD31) in patients with acute myocardial infarction. Arterioscler Thromb Vasc Biol 1999; 19: 153-8.
35. Shyu KG, Chang H, Lin CC, Kuan P. Circulating intercellular adhesion molecule-1 and E-selectin in patients with acute coronary syndrome. Chest 1996; 109: 1627-30.
36. Ghaisas NK, Shahi CN, Foley B, et al. Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina. Am J Cardiol 1997; 80: 617-9.
37. Gurbel PA, Serebruany VL. Soluble vascular cell adhesion molecule-1 and E-selectin in patients with acute myocardial infarction treated with thrombolytic agents. Am J Cardiol 1998; 81: 772-5.
38. Miwa K, Igawa A, Inoue H. Soluble E-selectin, ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina. Cardiovasc Res 1997; 36: 37-44.
39. Mulvihill N, Foley JB, Ghaisas N, Murphy R, Crean P, Walsh M. Early temporal expression of soluble cellular adhesion molecules in patients with unstable angina and subendocardial myocardial infarction. Am J Cardiol 1999; 83: 1265-7, A9.
40. Lefer AM, Weyrich AS, Buerke M. Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injury. Cardiovasc Res 1994; 28: 289-94.
41. Lefer DJ, Flynn DM, Phillips ML, Ratcliffe M, Buda AJ. A novel sialyl LewisX analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion. Circulation 1994; 90: 2390-401.
42. Kupatt C, Habazettl H, Zahler S, et al. ACE-inhibition prevents postischemic coronary leukocyte adhesion and leukocyte-dependent reperfusion injury. Cardiovasc Res 1997; 36: 386-95.
43. Feletou M, Bonnardel E, Canet E. Bradykinin and changes in microvascular permeability in the hamster cheek pouch: role of nitric oxide. Br J Pharmacol 1996; 118: 1371-6.
44. Koyama S, Rennard SI, Robbins RA. Bradykinin stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Physiol 1995; 269: L38-44.
45. Maruyama R, Hatta E, Levi R. Norepinephrine release and ventricular fibrillation in myocardial ischemia/reperfusion: roles of angiotensin and bradykinin. J Cardiovasc Pharmacol 1999; 34: 913-5.
46. Kurose I, Anderson DC, Miyasaka M, et al. Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res 1994; 74: 336-43.
47. Lefer AM, Tsao PS, Lefer DJ, Ma XL. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 1991; 5: 2029-34.
48. Eppihimer MJ, Russell J, Anderson DC, Epstein CJ, Laroux S, Granger DN. Modulation of P-selectin expression in the postischemic intestinal microvasculature. Am J Physiol 1997; 273: G1326-32.
49. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994; 46: 325-415.
50. Miyauchi T, Yanagisawa M, Tomizawa T, et al. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 1989; 2: 53-54.
51. Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 1991; 69: 370-7.
52. Luscher TF. The endothelium and cardiovascular disease - a complex relation. N Engl J Med 1994; 330: 1081-3.
53. Matsumura Y, Kita S, Okui T. Mechanisms of endothelin-1-induced potentiation of noradrenaline response in rat mesenteric artery. Clin Exp Pharmacol Physiol 2001; 28: 540-4.
54. Lopez FA, Riesco A, Espinosa G, et al. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 1993; 88: 1166-71.
55. Enseleit F, Hurlimann D, Luscher TF. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events. J Cardiovasc Pharmacol 2001; 37(Suppl. 1): S21-30.
56. Boldt J, Schindler E, Harter K, Gorlach G, Hempelmann G. Influence of intravenous administration of angiotensin-converting enzyme inhibitor enalaprilat on cardiovascular mediators in cardiac surgery patients. Anesth Analg 1995; 80: 480-5.
57. Gibson CM, Dotani MI, Murphy SA, et al. Correlates of coronary blood flow before and after percutaneous coronary intervention and their relationship to angiographic and clinical outcomes in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. Am Heart J 2002; 144: 130-5.
58. Gregorini L, Marco J, Kozakova M, et al. Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation 1999; 99: 482-90.